The Venari Podcast

What can nuclear medicine do for cancer research? Quite a lot, says PRecirix CTO Dimitrios Mantzilas | Talking RadioPharma Series

‘I’ve always been curious,’ Precirix Chief Technology Officer Dimitrios Mantzilas admits. It’s certainly served him well in his career in nuclear medicine. Matthew Palmer, Senior Oncology Consultant for our Life Sciences team, spoke to Dimitrios for this episode of the Venari Podcast’s Talking Radiopharma series. But what did we learn from their conversation?

From Big Pharma to biotech: building R&D teams with Sonya Montgomery

‘I’ve always really loved the biotech space,’ says Sonya Montgomery. An experienced Chief Medical Officer (CMO) with a strong focus on genomic medicine for rare diseases, Sonya has over 20 years of experience developing drugs across the US, Canada, the UK, and the Netherlands. Having most recently worked at Evox Therapeutics, Sonya has also offered her services as an independent consultant for the past decade. Paula Doust Alba, CNS & Rare Disease Consultant for our Life Sciences team, was delighted to catch up with Sonya on the Venari Podcast to discuss Sonya’s career to date, her thoughts on building teams in the space, and prevalent trends within research and development.

'The buck stops with me' - Emanuele Ostuni on life as a radiopharma CEO | Talking RadioPharma Series

Matthew Palmer, Senior Oncology Consultant for our life sciences practice, caught up with ARTBIO CEO Emanuele Ostuni for this episode of the Venari Podcast. You can read the transcript of the interview below for more on Emanuele’s career, what ARTBIO are working on, the challenges of being a CEO, and his thoughts on building teams for success.

Employee engagement and living company values with PPC Flexible Packaging CHRO, Amy Rodgers

‘Employee engagement remains such an important part of the work that we do as HR leaders – and, really, as business leaders,’ says Amy Rodgers. She’s been Chief Human Resources Officer at PPC Flexible Packaging since November 2022, and has plenty of wisdom to share about managing talent in the packaging space.
Tim Hartnell, Senior Consultant for our Sustainable Packaging practice, caught up with Amy on this episode of the Venari Podcast. Here are some of the key things we learned from their conversation!

'Chief Everything Officer' - from Edinburgh to L.A. with ImaginAb CEO, Ian Wilson | Talking RadioPharma Series

Matthew Palmer, Senior Oncology Consultant for our Life Sciences team, caught up with Ian for the first episode of ‘Talking Radiopharma’, Matthew’s new series for the Venari Podcast. Read on for Ian’s thoughts on life as a CEO, ImaginAb’s R&D in theragnostics, and key challenges the company looks set to face going forward. Ian also has some fascinating insights on team building, the key skillsets he looks for in talent, and advice for budding scientists and developers in his nuclear medicine.

‘Understand the role. Know what a Chief Commercial Officer does’ – Acorda CCO Kerry Clem opens up | CCO Series

‘I’ve always had the attitude that whatever is needed, wherever you need me to fill in, just let me know and we’ll take it on,’ says Acorda Therapeutics CCO, Kerry Clem. ‘I think that was one of the main things that helped me to elevate and grow.’ He’s amassed a wealth of commercial life sciences experience over her 25 years in the industry, joking that 13 years at Acorda alone make him ‘a relic in this industry’ – and so he was a natural candidate for inclusion on the BioPharma Chief Commercial Officer series for the Venari Podcast, run by our Life Sciences Commercial Lead, Joe Knight.

A conversation with Eric Luthi, CCO at Evergreen Theragnostics | CCO Series

“I can say definitively that the years working abroad were the most formative from a career and personal perspective – you learn so much when you take a role outside of your home market”. Fabulous to welcome Eric Luthi, Evergreen Theragnostics’s (relatively) recently appointed Chief Commercial Officer, to the Venari Podcast. We discuss building commercial infrastructure from scratch, how international experience has shaped his career and getting into the exciting world of radiopharmaceuticals. Radiopharma is a space that my colleague Matthew Palmer and I are doing a lot of work in currently, both on the R&D and commercial side. Get in touch if you’d like to learn more!

A conversation with Jens Noerterhaeuser, CEO & Co-founder of Kranus Health | HealthTech CEO Seires

From interior design to sustainability: a conversation with Amtrak’s Kara Oldhouser | The Sustainability Series

For Kara Oldhouser, what she describes as the ‘catalyst moment’ for her career in sustainability came after working in the commercial and architectural design space. Having studied interior design, she now had the chance to blend aesthetics with engineering and construction – and, with interest in environmental design increasing, Kara found herself drawn to learn more. She did a master’s in environmental studies and, after working with the built environment for a few years, joined Amtrak – the National Passenger Railroad of the U.S. – in 2017. Kara’s first position at Amtrak was in the real estate department – a development she describes as ‘a funny little story’: ‘The Environment Sustainability team sat right next to me and I became fast friends with everyone in that department,’ she recalls. ’90 days after starting [...] it was clear that my path was really meant for the sustainability manager position at the time’.
 
Seven years later, Kara is their Director of Sustainability – and Gov Kandola, who leads our Transport & Logistics team, was pleased to catch up with her for an episode of the Venari Podcast’s Sustainability series to discuss Kara’s career, Amtrak’s sustainable initiatives, and how this subject will influence future developments in her sector.

'A big, big, big change' is coming in the logistics sector, says Dr. Julia Hartmann | The Sustainability Series

In this episode of the Venari Podcast’s Sustainability Series, our Transport & Logistics lead, Gov Kandola, spoke to Dr. Julia Hartmann about DACHSER’s sustainability initiatives and the state of play in the sector at large. You can read the transcript of their full interview below.